Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > News
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by bromley1877on Nov 28, 2012 1:33pm
225 Views
Post# 20655870

RE: RE: News

RE: RE: News

Well that will indeed be the challenge of course; I am guessing that one road block now is the arbitraton since its findings witl determine what exlcusivity ISA has to offer interested third parties. It sounds like the hearing has been held and we are just waiting for the decision to come down.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities